Janus Henderson Investors

Diagonal Banks Another $125M for ‘Clustering’ Antibody Drugs

Circle Raises $222M To Launch Arc Blockchain Network

Modernize Fixed Income Portfolios With Income Alternatives

Parabilis Heads Biotech Fundraising Frenzy With $305M to Advance Cancer Drug

Ambrosia Eyes Next-Generation Small Molecule GLP-1s With $100M Series B

Voya Faces TOMS Capital Pressure to Explore Break-Up or Sale

Calyxo Pulls In $40M Series F Round

JPMorgan, Barclays, Fifth Third Sued by Investors for Missing ‘Giant Red Flags’ at Tricolor

The Biden Fiduciary Rule Is Officially Dead. What Comes Next?

MSD-Backed Ray Locks in $125m to Back Eye Drug Pipeline

Jana Partners Takes 5% Stake in Alkami Technology

Apple CEO Tim Cook Steps Down, John Ternus Named Successor in Executive Chairman Shift

The Week’s 10 Biggest Funding Rounds: XAI Leads As 2026 Is Off To A Brisk Start

“Three-Year Hump”: Janus Henderson Asia CEO Warns of “Musical Chairs” In Frothy Talent Market

10 Best Residential REITs to Buy in 2026

Wealth Managers Insist AI Can Work in Their Favour

Private Credit Jitters: Spillover Into CLO ETFs?

Multiliquid, Metalayer Launch Instant Redemption Backstop for RWAs on Solana

JMBS: Strong High-Quality MBS ETF, 5.5% Dividend Yield

InMed‑Mentari All‑Stock Merger Sends Shares Up 160% and Triggers $290 Million Private Placement

JAAA: Superior Risk-Adjusted Return Presents Unique Buying Opportunity

With Fixed Income, It’s Time to Think About Outcomes

Millennium Hires Former JPMorgan Credit Trader in London

Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement

Circle Adds $3 Billion Wall Street Arc Token Risking an Uncomfortable Rivalry with Coinbase

Standard Life’s Briggs Warns ‘Retirement Adequacy Is a Genuine Concern’, as £2bn Aegon Deal Unveiled

Why Flows Into Active ETFs Are Outpacing Total Market Share

How to De-Risk Your Portfolio in 5 Different Scenarios

Coinbase Picks Centrifuge as Tokenization Backbone, Takes Equity Stake

King Street Wins Saudi Backing for New Middle East-Focused Private Credit Fund

Stories of the Week: Schroders' AoV; The FCA Crackdown and UBS's Fee War

Munis Steady, New-Issue Calendar Grows to $13.5B

Caldera Therapeutics Launches with $112.5M in Total Capital

USDC Issuer Circle Raises $222M in Arc Token Presale Valued at $3B

Janus Henderson Calls for Defensive Carry in Multi‑Sector Credit Amid Middle East Conflict

Software Stocks See Worst Start to Year Since 2022 as AI Disruption Fears Mount

The Week’s 10 Biggest Funding Rounds: Security And Energy Deals Top The List

3 Top-Ranked Healthcare Mutual Funds With Solid Upside Potential

Ray's Upscaled Series B, and Other Biofinancings

3 Solid Mutual Funds to Grab on Surge Semiconductor Sales

BlossomHill Therapeutics Inks $84M Series B Extension

Citadel’s Global Fixed Income Strategy Hit by March Market Turmoil

Think Bioscience Raises $55M Series A

Coinbase Taps Centrifuge as Preferred Tokenization Partner

Inflation Goes up by a Whopping Monthly Rate of Nearly 1%—And It’s Hitting You at the Grocery Store and Gas Station

Analysis-Bond Yield Spike Is Risk to Unprepared Equities Market, Investors Warn

New Frontier In The Gulf

Windward Bio Secures $165 Million to Accelerate Late‑Stage Asthma and COPD Trials

CesiumAstro to Scale Operations with $470 Million in Equity and Debt Financing

CesiumAstro Raises $470M in Growth Capital, CEO Sabripour Calls It a ‘Scale Moment’

Think Bioscience Secures $55M Series A Funding

Kailera Therapeutics Secures $600M Series B Funding Led by Bain Capital Private Equity

BlossomHill Therapeutics Secures $84M Series B Extension Funding

Parabilis Medicines Secures $305M Series F Funding Led by RA Capital, Fidelity Management, and Janus Henderson

Ambrosia Biosciences Secures $100M Series B Funding

Calyxo Secures $40M Series F Funding Round

BlossomHill Therapeutics Secures $84M Series B Extension

Ray Therapeutics Closes $125M Series B to Advance Vision‑Restoring Therapies